UPDATE: UBS Starts Intra-Cellular Therapies (ITCI) at Buy
Tweet Send to a Friend
(Updated - June 13, 2022 4:54 PM EDT)
UBS analyst Ashwani Verma initiates coverage on Intra-Cellular Therapies (NASDAQ: ITCI) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst Ashwani Verma initiates coverage on Intra-Cellular Therapies (NASDAQ: ITCI) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
